Journal of Gastroenterology and Hepatology

期刊全称

期刊缩写

J GASTROEN HEPATOL

涉及主题

医学内科学生物胃肠病学遗传学病理外科化学生物化学免疫学放射科内分泌学

期刊介绍

Journal of Gastroenterology and Hepatology is produced 12 times per year and publishes peer-reviewed original papers, reviews and editorials concerned with clinical practice and research in the fields of hepatology, gastroenterology and endoscopy. Papers cover the medical, radiological, pathological, biochemical, physiological and historical aspects of the subject areas. All submitted papers are reviewed by at least two referees expert in the field of the submitted paper.

期刊ISSN

print: 0815-9319 on-line: 1440-1746

历年影响因子

2025年	2024年	2023年	2022年	2021年	2020年	2019年	2018年
3.4	3.7	4.1	4.369	4.029	3.437	3.632	3.483

历年发表/被引量

年份	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
发表量	493	418	421	366	346	435	466	406	423	441	386	446
被引量	263	912	2287	2603	3991	6513	9622	7671	8128	10817	8558	12401

h-Index

117

自引率

2.70%

涉及的研究领域

医学-胃肠肝病学

2026年新锐分区

大类	小类	TOP期刊	综述期刊
3区	3区胃肠肝病学	否	N/A

中科院2025年分区

大类	小类	TOP期刊	综述期刊
3区	3区胃肠肝病学	否	否

WOS期刊分区

JCR学科分类

JCR分区学科名称	收录数据库	JCR分区	分区排名
GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	54/153

JCI学科分类

JCI分区学科名称	收录数据库	JCI分区	分区排名
GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	60/153

期刊主页

http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-1746 https://onlinelibrary.wiley.com/journal/14401746

投稿网址

http://mc.manuscriptcentral.com/jgh

出版商

Wiley-Blackwell Publishing Ltd

出版国家（地区）

AUSTRALIA

出版语言

English

出版周期

Monthly

每年出版文章数

288

Gold OA文章占比

13.22%

原创研究文献占比
(排除综述)

77.87%

SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

PubMed链接

http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0815-9319%5BISSN%5D

平均审稿周期

平均2.3月

平均录用比例

约62.5%

Journal of Gastroenterology and Hepatology

JCR学科分类

JCI学科分类

期刊相关文献 (500)

Psychosine Alleviates Colitis via Inhibiting Th1 and Th17 Cell Immune Responses in Inflammatory Bowel Diseases

Psychosine通过抑制炎症性肠病中的Th1和Th17细胞免疫反应来缓解结肠炎

Dose Reduction of Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients With Complete Biochemical Response: An Open-Label Randomized Clinical Trial

熊去氧胆酸剂量减少治疗原发性胆汁性胆管炎患者，可获得完全生化缓解：一项开放标签随机临床试验

Agile 3+ Score in CHB-MASLD: A Paradigm Shift or a Context-Specific Victory?

CHB-MASLD 中的敏捷 3+ 得分：范式转变还是特定情境下的胜利？

Methodological Points to Consider for VCAM-1 as a Relapse Predictor in Ulcerative Colitis

VCAM-1作为溃疡性结肠炎复发预测因子时需要考虑的方法学要点

Letter to the Editor: 5-Year Outcomes and Disease Trajectories in Moderate-to-Severe Ulcerative Colitis: A Korean Multicenter Inception Cohort

致编辑的信：中重度溃疡性结肠炎的5年预后和疾病轨迹：一项韩国多中心初始队列研究

Comment on "Five-Year Outcomes and Disease Trajectories in Moderate-to-Severe Ulcerative Colitis: A Korean Multicenter Inception Cohort"

对“中重度溃疡性结肠炎五年预后及疾病轨迹：韩国多中心初始队列研究”的评论

Interpreting Histological Adequacy in EUS-Guided Liver Biopsy: Clinical Context Matters

解读超声内镜引导下肝脏活检的组织学充分性：临床背景至关重要

Methodological Concerns Regarding the Primary Endpoint and External Validity in the Randomized Trial of EUS-Guided Versus Percutaneous Liver Biopsy

EUS引导下肝活检与经皮肝活检随机试验中主要终点和外部有效性的方法学问题

Letter to the Editor: Randomized Controlled Trial of Endoscopic Ultrasound-Guided Liver Biopsy Versus Percutaneous Liver Biopsy for Obtaining Histologically Adequate Specimens

致编辑的信：内镜超声引导下肝活检与经皮肝活检获取组织学标本的随机对照试验

Comment on: Epidermal Growth Factor Receptor Pathway Is a Potential Biological Mechanism in Inflammatory Bowel Disease-Induced Psoriasis

评论：表皮生长因子受体通路是炎症性肠病诱发银屑病的潜在生物学机制